Skip to content
OpenCapital
Get started
Pediatrix Medical Group logo

Pediatrix Medical Group (MD) Q1 2026 Earnings

MD·Reported May 5, 2026·Before market open

Pediatrix Medical Group reported Q1 2026 revenue of $476.2M (+3.9% YoY), beat analyst consensus of $465.8M by $10.4M. Diluted EPS came in at $0.44 (+33.3% YoY), beat the $0.37 consensus by $0.07.

Revenue
$476.2Mbeat by $10.4M
Consensus: $465.8M
Diluted EPS
$0.44beat by $0.07
Consensus: $0.37
SEC

SEC Filings

Earnings release8-K · 0001193125-26-204982
Quarterly report10-Q · 0001193125-26-204993

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Pediatrix Medical Group's Q1 2026 earnings report.

Pediatrix Medical Group (MD) reported Q1 2026 earnings on May 5, 2026 before market open.

Pediatrix Medical Group reported revenue of $476.2M and diluted EPS of $0.44 for Q1 2026.

Revenue beat the consensus estimate of $465.8M by $10.4M. EPS beat the consensus estimate of $0.37 by $0.07.

Compared to the same quarter a year prior, revenue grew 3.9% from $458.4M a year earlier and diluted EPS grew 33.3% from $0.33.

You can read the 8-K earnings release (0001193125-26-204982) and the 10-Q periodic report (0001193125-26-204993) directly on SEC EDGAR. The filing index links above go to sec.gov.